Literature DB >> 3122764

Direct experimental evidence for competitive inhibition of dihydrofolate reductase by methotrexate.

M C Waltham1, J W Holland, S C Robinson, D J Winzor, P F Nixon.   

Abstract

Steady-state enzyme kinetic techniques at very low enzyme concentration (0.4 nM) were used successfully to measure the inhibition constant (53 pM) for the dissociation of methotrexate from the ternary complex of methotrexate, NADPH and dihydrofolate reductase from Lactobacillus casei; and to demonstrate unequivocally that the inhibition was, indeed, competitive with respect to dihydrofolate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3122764     DOI: 10.1016/0006-2952(88)90225-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate.

Authors:  R Goel; R Sanga; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Mechanism of Action of Methotrexate Against Zika Virus.

Authors:  Sungjun Beck; Zhe Zhu; Michelli F Oliveira; Davey M Smith; Jeremy N Rich; Jean A Bernatchez; Jair L Siqueira-Neto
Journal:  Viruses       Date:  2019-04-10       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.